Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Inspire Medical Systems Inc INSP

Inspire Medical Systems, Inc. is a medical technology company. The Company is focused on the development and commercialization of advanced, minimally invasive solutions for patients with obstructive sleep apnea (OSA). Its proprietary Inspire therapy is the FDA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. It has... see more

Recent & Breaking News (NYSE:INSP)

Inspire Medical Systems, Inc. Announces Changes to its Board of Directors

GlobeNewswire July 25, 2019

Inspire Medical Systems, Inc. to Report Second Quarter 2019 Financial Results on August 6, 2019

GlobeNewswire July 9, 2019

Inspire Medical Systems, Inc. Announces UnitedHealthcare Coverage for Inspire Therapy for the Treatment of Obstructive Sleep Apnea

GlobeNewswire July 8, 2019

EY Names Tim Herbert, President & CEO of Inspire Medical Systems, Inc., Entrepreneur Of The Year® 2019 Award Winner in the Heartland

GlobeNewswire July 1, 2019

Inspire Medical Systems, Inc. Announces Publication Demonstrating Effectiveness of Inspire Therapy in Treating Obstructive Sleep Apnea in Medicare-aged Patients

GlobeNewswire May 14, 2019

Inspire Medical Systems, Inc. to Present at the 2019 RBC Capital Markets Global Healthcare Conference

GlobeNewswire May 8, 2019

Inspire Medical Systems, Inc. Announces First Quarter 2019 Financial Results and Increases 2019 Outlook

GlobeNewswire May 7, 2019

Inspire Medical Systems, Inc. Announces Additional 11.2 Million Covered Lives with New Blue Cross Blue Shield Coverage Policies

GlobeNewswire May 6, 2019

Inspire Medical Systems, Inc. to Present at the Bank of America Merrill Lynch Health Care Conference 2019

GlobeNewswire May 2, 2019

Inspire Medical Systems, Inc. Announces an Additional 10.4 Million Covered Lives with New Coverage Policies

GlobeNewswire April 25, 2019

Inspire Medical Systems, Inc. Announces the 5,000th Patient to Receive Inspire Therapy

GlobeNewswire April 16, 2019

Inspire Medical Systems, Inc. Announces Five New Positive Coverage Policies Issued by Blue Cross Blue Shield Plans

GlobeNewswire March 4, 2019

Inspire Medical Systems, Inc. Announces Fourth Quarter and Full Year 2018 Financial Results

GlobeNewswire February 26, 2019

Inspire Medical Systems, Inc. to Present at the 8th Annual SVB Leerink Global Healthcare Conference

GlobeNewswire February 14, 2019

Inspire Medical Systems, Inc. to Report Fourth Quarter and Fiscal 2018 Financial Results on February 26

GlobeNewswire February 5, 2019

Inspire Medical Systems, Inc. Announces Additional Positive Coverage Policies Issued by Five Blue Cross Blue Shield Healthcare Plans

GlobeNewswire February 5, 2019

Inspire Medical Systems, Inc. Announces a Positive Coverage Policy Issued by Blue Cross Blue Shield of North Carolina

GlobeNewswire January 31, 2019

Inspire Medical Systems, Inc. Announces FDA Approval of New Sensing Lead

GlobeNewswire January 29, 2019

Inspire Medical Systems, Inc. Announces a Positive Coverage Policy Issued by Horizon Blue Cross Blue Shield of New Jersey

GlobeNewswire January 16, 2019

Inspire Medical Systems, Inc. Announces First BCBS Coverage Policy following Evidence Street’s Positive Therapy Indication Summary

GlobeNewswire January 14, 2019